Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis
Phase 1
Completed
- Conditions
- Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
- Interventions
- Drug: OA-235i (4 mg)Drug: OA-235i (8 mg)Drug: OA-235i (16 mg)Drug: OA-235i (30 mg)Drug: OA-235i (40 mg)Drug: OA-235i or placebo
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Oasis Pharmaceuticals, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT05680233
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
News
No news found